Seeking Alpha

Optimer Pharmaceuticals (OPTR +3.8%) trades up after BMC initiates the shares with a buy. The...

Optimer Pharmaceuticals (OPTR +3.8%) trades up after BMC initiates the shares with a buy. The firm says the company's newly launched antibiotic, Dificid, will exceed sales expectations in both the near and longer term.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)